RARE Ultragenyx Pharmaceutical Inc. - Common Stock
$26.41
가격 · 8월 19, 2026
기준 재무 정보 8월 5, 2026
52주 범위
$18–$40
38% of range
애널리스트 평점
BUY
25 analysts
목표 주가
$53
+100% upside
P/E (TTM)
-4.6
ROE
-1613.2%
순이익률
-85.4%
RARE 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$26.41
시가총액
$2.60B
P/E (TTM)
-4.6
EPS (TTM)
$-5.83
매출 (TTM)
$673M
배당 수익률
—
ROE
-1613.2%
부채/자본
—
52주 범위
$18 – $40
RARE 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$673M
2016-12-31
→
2025-12-31
EPS
$-5.83
2020-12-31
→
2025-12-31
잉여현금흐름
$-472M
2016-12-31
→
2025-12-31
마진
-85.4%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
RARE
동종업계 중앙값
P/E (TTM)
-4.6
97.6
P/S (TTM)
3.9
7.7
P/B
-32.4
8.0
Price / FCF (주가 / FCF)
-5.5
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
RARE
동종업계 중앙값
Operating Margin (영업이익률)
-79.5%
—
Net Profit Margin (순이익률)
-85.4%
-51.7%
ROA
-37.9%
-44.2%
ROE
-1613.2%
-63.5%
ROIC
673.4%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
RARE
동종업계 중앙값
Current Ratio (유동비율)
2.5
4.9
Quick Ratio (당좌 비율)
1.5
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
RARE
동종업계 중앙값
Revenue YoY (매출 YoY)
20.2%
—
Revenue CAGR 3Y (매출 CAGR 3년)
22.8%
—
Revenue CAGR 5Y (매출 CAGR 5년)
20.0%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
RARE
동종업계 중앙값
RARE 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
25 명의 애널리스트
- 적극 매수 8 32.0%
- 매수 14 56.0%
- 보유 3 12.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
19 명의 애널리스트 · 2026-08-15
중앙값
$46.00
평균
$52.84
← 모든 목표가 하회
$26.41
저가
$27.00
고가
$96.00
중앙값 목표
$46.00
+74.2%
평균 목표
$52.84
+100.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.08%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.90 | $-1.24 | 0.34% |
| 2026년 3월 31일 | $-1.84 | $-1.54 | -0.30% |
| 2025년 12월 31일 | $-1.29 | $-1.11 | -0.18% |
| 2025년 9월 30일 | $-1.81 | $-1.26 | -0.55% |
| 2025년 6월 30일 | $-1.17 | $-1.32 | 0.15% |
| 2025년 3월 31일 | $-1.57 | $-1.65 | 0.08% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| KOD | $1.73B | -6.5 | — | — | -202.0% | — |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| COAG | — | — | — | — | — | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Cost of Revenue | · | · | · | · | · | · | · | $1M | $1.0K | · | |
| R&D Expense | $750M | $698M | $648M | $706M | $497M | $412M | $357M | $294M | $232M | $183M | |
| SG&A Expense | $349M | $321M | $310M | $278M | $220M | $183M | $162M | $128M | $100M | $65M | |
| Operating Expenses | · | · | · | · | · | $601M | $528M | $423M | $332M | $248M | |
| Operating Income | $-535M | $-536M | $-569M | $-649M | $-382M | $-330M | $-424M | $-371M | $-329M | $-248M | |
| Interest Income | $25M | $37M | $27M | $11M | $2M | $7M | $13M | $10M | $4M | $4M | |
| Other Non-op | $1M | $-5M | $-1M | $-2M | $-2M | $607.0K | $-787.0K | $-6M | $7M | $-2M | |
| Pretax Income | $-571M | $-567M | $-609M | $-702M | $-453M | $-185M | $-399M | $-197M | $-318M | $-246M | |
| Income Tax | $4M | $2M | $-2M | $6M | $1M | $1M | $3M | $514.0K | $-16M | $35.0K | |
| Net Income | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| EPS (Basic) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| EPS (Diluted) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| Shares (Basic) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| Shares (Diluted) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| EBITDA | $-500M | $-500M | $-543M | $-631M | $-368M | $-318M | $-416M | $-352M | $-323M | $-245M |
대차대조표 29
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $421M | $174M | $214M | $133M | $308M | $714M | $434M | $113M | $100M | $161M | |
| Short-term Investments | · | · | · | · | · | · | $322M | $346M | $134M | $219M | |
| Receivables | $158M | $122M | $73M | $40M | $28M | $23M | $33M | $13M | $5M | · | |
| Inventory | $52M | $45M | $34M | $27M | $16M | $13M | $12M | $7M | $757.0K | · | |
| Prepaid Expense | $61M | $40M | $48M | $69M | $72M | $58M | $51M | $43M | $29M | $20M | |
| Other Current Assets | · | · | $48M | $69M | · | · | · | · | · | · | |
| Current Assets | $951M | $817M | $732M | $884M | $857M | $1.30B | $851M | $522M | $270M | $402M | |
| PP&E (Net) | $244M | $266M | $291M | $260M | $141M | $74M | $44M | $20M | $22M | $17M | |
| PP&E (Gross) | $380M | $378M | $374M | $323M | $191M | $111M | $70M | $38M | $33M | $23M | |
| Accum. Depreciation | $136M | $112M | $83M | $63M | $50M | $37M | $26M | $18M | $11M | $6M | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | |
| Intangibles | $176M | $178M | $166M | $160M | $131M | $131M | $129M | $129M | $142M | · | |
| Other Non-current Assets | $60M | $63M | $58M | $48M | $21M | $9M | $3M | $4M | $3M | $2M | |
| Total Assets | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Accounts Payable | $31M | $39M | $42M | $43M | $17M | $13M | $13M | $12M | $9M | $5M | |
| Accrued Liabilities | $265M | $241M | $196M | $205M | $146M | $108M | $83M | $62M | $62M | $55M | |
| Current Liabilities | $384M | $344M | $280M | $261M | $181M | $190M | $103M | $75M | $71M | $60M | |
| Capital Leases | $24M | $30M | $31M | $20M | $30M | $39M | $30M | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $32M | $33M | $33M | $33M | $31M | $31M | · | |
| Other Non-current Liabilities | $44M | $17M | $12M | $5M | $1M | $7M | · | $5M | $5M | $6M | |
| Total Liabilities | $1.60B | $1.24B | $1.22B | $1.19B | $600M | $605M | $482M | $111M | $107M | $67M | |
| Common Stock | $0 | $0 | $82.0K | $70.0K | $69.0K | $67.0K | $58.0K | $51.0K | $44.0K | $41.0K | |
| Paid-in Capital | $4.45B | $4.21B | $3.66B | $3.14B | $3.00B | $2.77B | $2.09B | $1.64B | $1.22B | $1.00B | |
| Retained Earnings | $-4.53B | $-3.96B | $-3.39B | $-2.78B | $-2.07B | $-1.62B | $-1.43B | $-1.03B | $-833M | $-531M | |
| Treasury Stock | $8M | $4M | $432.0K | $0 | · | · | · | · | · | · | |
| AOCI | $1M | $-1M | $647.0K | $-7M | $-1M | $689.0K | $-147.0K | $-633.0K | $-6M | $905.0K | |
| Stockholders' Equity | $-80M | $255M | $275M | $352M | $923M | $1.15B | $654M | $609M | $383M | $474M | |
| Liabilities + Equity | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Shares Outstanding | 96,600,000 | 92,500,000 | 82,300,000 | 70,200,000 | 69,344,998 | 66,818,520 | 57,838,220 | 50,860,588 | 44,167,071 | 41,240,230 |
현금 흐름 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $35M | $36M | $26M | $18M | $13M | $12M | $9M | $20M | $6M | $3M | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $68M | $48M | |
| Deferred Tax | · | $-1M | $-2M | $2M | · | · | $2M | · | $-16M | · | |
| Other Non-cash | $74M | $118M | $104M | $310M | $102M | $42M | $47M | $-112M | $-9M | $33M | |
| Operating Cash Flow | $-466M | $-414M | $-475M | $-380M | $-339M | $-132M | $-345M | $-291M | $-254M | $-161M | |
| CapEx | $6M | $7M | $44M | $116M | $73M | $44M | $25M | $4M | $3M | $10M | |
| Investing Cash Flow | $236M | $-18M | $168M | $-292M | $-195M | $-179M | $-13M | $-33M | $55M | $91M | |
| Stock Issued | · | · | · | $0 | $0 | $436M | $330M | $271M | · | · | |
| Net Stock Activity | · | · | · | $0 | · | $436M | $330M | $271M | · | · | |
| Financing Cash Flow | $478M | $399M | $388M | $501M | $119M | $600M | $679M | $337M | $136M | $139M | |
| Net Change in Cash | $252M | $-35M | $81M | $-172M | $-417M | $290M | $321M | $12M | $-62M | $69M | |
| Taxes Paid | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-472M | $-422M | $-519M | $-497M | $-412M | $-176M | $-370M | $-295M | $-257M | $-171M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% | -121.8% | -409.0% | -721.2% | -12593.5% | -186471.4% | |
| Net Margin | -85.4% | -101.6% | -139.7% | -194.7% | -129.2% | -68.8% | -388.3% | -383.8% | -11567.3% | -184867.7% | |
| Pretax Margin | -84.8% | -101.3% | -140.1% | -193.1% | -128.9% | -68.4% | -385.1% | -382.8% | -12187.5% | -184841.4% | |
| EBITDA Margin | -74.3% | -89.3% | -125.1% | -173.6% | -104.9% | -117.3% | -400.8% | -683.2% | -12370.5% | -183897.0% | |
| ROA | -37.9% | -38.0% | -40.0% | -46.1% | -27.7% | -12.9% | -43.4% | -32.6% | -58.6% | -44.7% | |
| ROE | -1613.2% | -189.1% | -395.0% | -172.3% | -48.9% | -20.5% | -58.3% | -31.1% | -70.5% | -48.9% | |
| ROIC | 673.4% | -210.5% | -206.1% | -185.6% | -41.5% | -28.8% | -65.4% | -61.2% | -81.4% | -52.3% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 | 6.8 | 8.2 | 7.0 | 3.8 | 6.7 | |
| Quick Ratio | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 | 3.9 | 7.6 | 6.3 | 3.4 | 6.3 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.3 | 0.0 | · | |
| Receivables Turnover | 4.8 | 5.7 | 7.6 | 10.6 | 13.6 | 9.7 | 4.6 | 5.7 | 1.0 | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 20.2% | 29.0% | 19.4% | 3.4% | 29.7% | · | · | · | · | · | |
| Revenue CAGR 3Y | 22.8% | 16.8% | 17.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.0% | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Net Income TTM | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| Market Cap | $2.22B | $3.89B | $3.94B | $3.25B | $5.83B | $9.25B | $2.47B | $2.21B | $2.05B | $2.90B | |
| P/E | -3.9 | -6.7 | -5.8 | -4.6 | -12.6 | -45.1 | -6.1 | -11.1 | · | · | |
| P/S | 3.3 | 6.9 | 9.1 | 9.0 | 16.6 | 34.1 | 23.8 | 42.9 | 784.3 | 21801.5 | |
| P/B | -27.8 | 15.2 | 14.3 | 9.2 | 6.3 | 8.0 | 3.8 | 3.6 | 5.3 | 6.1 | |
| P / Tangible Book | · | 117.9 | 61.2 | 22.1 | 7.8 | 9.4 | · | · | · | · | |
| P / Cash Flow | -4.8 | -9.4 | -8.3 | -8.5 | -17.2 | -70.0 | -7.2 | -7.6 | -8.1 | -18.0 | |
| P / FCF | -4.7 | -9.2 | -7.6 | -6.5 | -14.2 | -52.5 | -6.7 | -7.5 | -8.0 | -16.9 | |
| Earnings Yield | -25.4% | -14.9% | -17.2% | -21.8% | -8.0% | -2.2% | -16.4% | -9.0% | · | · |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $214M | $136M | $207M | $160M | $167M | $139M | $165M | $139M | $147M | $109M | $127M | $98M | $108M | $100M | $103M | $91M | |
| R&D Expense | $167M | $187M | $203M | $216M | $165M | $166M | $188M | $170M | $162M | $178M | $160M | $157M | $165M | $166M | $171M | $237M | |
| SG&A Expense | $88M | $88M | $88M | $87M | $87M | $87M | $82M | $80M | $81M | $78M | $77M | $75M | $81M | $77M | $73M | $70M | |
| Operating Income | $-75M | $-169M | $-113M | $-171M | $-108M | $-143M | $-122M | $-132M | $-116M | $-165M | $-122M | $-145M | $-148M | $-154M | $-146M | $-225M | |
| Interest Income | $5M | $6M | $7M | $6M | $6M | $7M | $10M | $11M | $7M | $9M | $9M | $6M | $6M | $6M | $6M | $3M | |
| Other Non-op | $1M | · | $-934.0K | $-1M | $2M | $837.0K | $-5M | $3M | $-2M | $-2M | $1M | $-699.0K | $-2M | $308.0K | $180.0K | $-1M | |
| Pretax Income | $-91M | $-184M | $-128M | $-180M | $-114M | $-150M | $-133M | $-133M | $-131M | $-170M | $-127M | $-159M | $-159M | $-163M | $-153M | $-239M | |
| Income Tax | $1M | $1M | $870.0K | $873.0K | $1M | $1M | $384.0K | $303.0K | $858.0K | $455.0K | $-4M | $650.0K | $732.0K | $495.0K | $-1M | $6M | |
| Net Income | $-92M | $-185M | $-129M | $-180M | $-115M | $-151M | $-133M | $-134M | $-132M | $-171M | $-124M | $-160M | $-160M | $-164M | $-152M | $-245M | |
| EPS (Basic) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| EPS (Diluted) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| Shares (Basic) | 101,900,000 | 100,600,000 | -195,920,392 | 99,771,297 | 98,500,000 | 96,300,000 | -175,860,804 | 95,493,996 | 86,580,516 | 84,286,292 | -139,430,962 | 71,664,493 | 70,897,991 | 70,368,478 | -139,581,974 | 70,054,173 | |
| Shares (Diluted) | 101,900,000 | 100,600,000 | -195,920,392 | 99,771,297 | 98,500,000 | 96,300,000 | -175,860,804 | 95,493,996 | 86,580,516 | 84,286,292 | -139,430,962 | 71,664,493 | 70,897,991 | 70,368,478 | -139,581,974 | 70,054,173 | |
| EBITDA | $-75M | $-161M | · | $-171M | $-108M | $-134M | · | $-132M | $-116M | $-157M | · | $-145M | $-148M | $-149M | · | $-225M |
대차대조표 28
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $175M | $421M | $203M | $176M | $127M | $174M | $151M | $481M | $112M | $214M | $73M | $102M | $86M | $133M | $392M | |
| Receivables | $200M | $121M | $158M | $113M | $124M | $99M | $122M | $93M | $106M | $100M | · | $79M | $71M | $43M | · | $31M | |
| Inventory | $59M | $55M | $52M | $52M | $46M | $46M | $45M | $43M | $40M | $36M | · | $32M | $28M | $27M | · | $22M | |
| Prepaid Expense | $55M | $68M | $61M | $53M | $61M | $60M | $40M | · | · | · | · | $46M | $51M | $67M | · | $71M | |
| Other Current Assets | · | · | · | · | · | · | · | $41M | $55M | $48M | · | · | · | · | · | · | |
| Current Assets | $606M | $657M | $951M | $643M | $720M | $699M | $817M | $800M | $965M | $596M | · | $599M | $702M | $766M | · | $1.01B | |
| PP&E (Net) | $235M | $239M | $244M | $250M | $256M | $261M | $266M | $272M | $279M | $285M | · | $297M | $289M | $278M | · | $235M | |
| PP&E (Gross) | · | · | $380M | · | · | · | $378M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $136M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | $44M | $44M | $44M | · | $44M | |
| Intangibles | $172M | $174M | $176M | $173M | $175M | $177M | $178M | $165M | $166M | $165M | · | $157M | $158M | $159M | · | $158M | |
| Other Non-current Assets | $63M | $61M | $60M | $58M | $60M | $62M | $63M | $54M | $54M | $60M | · | $28M | $26M | $22M | · | $18M | |
| Total Assets | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Accounts Payable | $39M | $42M | $31M | $41M | $34M | $47M | $39M | $36M | $60M | $41M | · | $33M | $42M | $59M | · | $24M | |
| Accrued Liabilities | $221M | $194M | $265M | $221M | $181M | $173M | $241M | $185M | $154M | $149M | · | $179M | $168M | $144M | · | $189M | |
| Current Liabilities | $351M | $325M | $384M | $340M | $293M | $292M | $344M | $285M | $273M | $246M | · | $254M | $244M | $218M | · | $227M | |
| Capital Leases | · | · | $24M | $22M | $25M | $28M | $30M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | · | $32M | $32M | $32M | · | $33M | |
| Other Non-current Liabilities | $41M | $42M | $20M | $19M | $17M | $17M | $17M | $16M | $15M | $14M | · | $10M | $10M | $9M | · | $4M | |
| Total Liabilities | $1.55B | $1.52B | $1.60B | $1.17B | $1.15B | $1.16B | $1.24B | $1.18B | $1.19B | $1.17B | · | $1.21B | $1.18B | $1.16B | · | $1.15B | |
| Common Stock | $0 | $0 | $0 | $96.0K | $96.0K | $94.0K | $0 | $92.0K | $92.0K | $83.0K | · | $72.0K | $71.0K | $71.0K | · | $70.0K | |
| Paid-in Capital | $4.52B | $4.48B | $4.45B | $4.41B | $4.37B | $4.25B | $4.21B | $4.17B | $4.12B | $3.70B | · | $3.30B | $3.24B | $3.17B | · | $3.11B | |
| Retained Earnings | $-4.81B | $-4.72B | $-4.53B | $-4.40B | $-4.22B | $-4.11B | $-3.96B | $-3.82B | $-3.69B | $-3.56B | · | $-3.26B | $-3.10B | $-2.94B | · | $-2.63B | |
| Treasury Stock | $10M | $10M | $8M | $8M | $8M | $8M | $4M | $4M | $3M | $3M | · | $381.0K | $381.0K | $356.0K | · | · | |
| AOCI | $0 | $0 | $1M | $820.0K | $-268.0K | $-341.0K | $-1M | $896.0K | $-1M | $-431.0K | · | $-2M | $-3M | $-4M | · | $-10M | |
| Stockholders' Equity | $-291M | $-236M | $-80M | $9M | $151M | $144M | $255M | $347M | $432M | $140M | $275M | $32M | $129M | $220M | $352M | $469M | |
| Liabilities + Equity | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Shares Outstanding | 98,600,000 | 98,300,000 | 96,600,000 | 96,442,027 | 96,353,634 | 93,903,785 | 92,500,000 | 92,304,317 | 92,135,384 | 83,094,037 | 82,300,000 | 72,174,307 | 71,465,424 | 70,660,249 | 70,197,297 | 70,079,777 |
현금 흐름 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $9M | $9M | $9M | $9M | $10M | $9M | $9M | $9M | $8M | $7M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-20M | · | · | · | $-24M | · | · | · | $-29M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-97M | $-197M | $-100M | $-91M | $-108M | $-166M | $-79M | $-67M | $-77M | $-191M | $-84M | $-118M | $-116M | $-157M | $-90M | $-95M | |
| CapEx | $1M | $1M | $938.0K | $1M | $2M | $1M | $163.0K | $2M | $2M | $3M | $1M | $4M | $14M | $25M | $27M | $26M | |
| Investing Cash Flow | $44M | $-49M | $-72M | $117M | $71M | $120M | $103M | $-276M | $61M | $94M | $-107M | $64M | $99M | $111M | $-172M | $-162M | |
| Financing Cash Flow | · | · | $394M | $2.0K | $84M | $157.0K | $3M | $11M | $385M | $-58.0K | $330M | $25M | $33M | $-722.0K | $2M | $492M | |
| Net Change in Cash | $-49M | $-247M | $221M | $26M | $49M | $-45M | $24M | $-330M | $368M | $-97M | $140M | $-29M | $16M | $-46M | $-259M | $234M | |
| Free Cash Flow | · | $-198M | · | · | · | $-168M | · | · | · | $-194M | · | · | · | $-182M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -35.0% | -124.3% | · | -106.8% | -64.8% | -102.6% | · | -94.6% | -79.1% | -151.9% | · | -148.0% | -136.6% | -153.3% | · | -248.1% | |
| Net Margin | -43.0% | -136.0% | · | -112.8% | -69.0% | -108.5% | · | -95.7% | -89.5% | -156.8% | · | -162.8% | -147.6% | -163.2% | · | -270.2% | |
| Pretax Margin | -42.5% | -135.3% | · | -112.3% | -68.5% | -107.5% | · | -95.5% | -88.9% | -156.4% | · | -162.2% | -146.9% | -162.7% | · | -263.3% | |
| EBITDA Margin | -35.0% | -118.4% | · | -106.8% | -64.8% | -96.2% | · | -94.6% | -79.1% | -143.8% | · | -148.0% | -136.6% | -148.1% | · | -248.1% | |
| ROA | -7.2% | -14.2% | · | -13.2% | -7.9% | -11.5% | · | -9.6% | -9.0% | -12.7% | · | -11.2% | -12.2% | -11.8% | · | -15.8% | |
| ROE | 131.7% | 403.2% | · | -101.4% | -39.4% | -106.2% | · | -70.5% | -46.9% | -94.6% | · | -63.8% | -39.6% | -32.2% | · | -34.9% | |
| ROIC | 26.1% | 72.0% | · | -1874.9% | -71.9% | -100.0% | · | -38.1% | -27.1% | -118.2% | · | -459.4% | -115.2% | -70.1% | · | -49.3% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 2.0 | · | 1.9 | 2.5 | 2.4 | · | 2.8 | 3.5 | 2.4 | · | 2.4 | 2.9 | 3.5 | · | 4.5 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.0 | 0.8 | · | 0.9 | 2.1 | 0.9 | · | 0.6 | 0.7 | 0.6 | · | 1.9 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.6 | 1.4 | 1.4 | · | 1.6 | 1.7 | 1.5 | · | 1.8 | 2.0 | 2.8 | · | 3.2 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $677M | $601M | · | $605M | $592M | $535M | · | $493M | $462M | $416M | · | $398M | $389M | $360M | · | $342M | |
| Net Income TTM | $-572M | $-631M | · | $-580M | $-531M | $-587M | · | $-595M | $-622M | $-654M | · | $-729M | $-727M | $-720M | · | $-629M | |
| Market Cap | $3.29B | $2.06B | · | $2.90B | $3.50B | $3.40B | · | $5.13B | $3.79B | $3.88B | · | $2.57B | $3.30B | $2.83B | · | $2.90B | |
| P/E | -5.8 | -3.3 | · | -5.1 | -6.4 | -5.6 | · | -7.7 | -5.1 | -5.3 | · | -3.5 | -4.5 | -3.9 | · | -4.6 | |
| P/S | 4.9 | 3.4 | · | 4.8 | 5.9 | 6.4 | · | 10.4 | 8.2 | 9.3 | · | 6.5 | 8.5 | 7.9 | · | 8.5 | |
| P/B | -11.3 | -8.7 | · | 316.7 | 23.2 | 23.6 | · | 14.8 | 8.8 | 27.7 | · | 81.1 | 25.5 | 12.9 | · | 6.2 | |
| P / Tangible Book | · | · | · | · | · | · | · | 37.3 | 17.1 | · | · | · | · | 167.6 | · | 10.9 | |
| P / Cash Flow | · | -10.5 | · | · | · | -20.4 | · | · | · | -20.3 | · | · | · | -18.1 | · | · | |
| P / FCF | · | -10.4 | · | · | · | -20.3 | · | · | · | -20.0 | · | · | · | -15.6 | · | · | |
| Earnings Yield | -17.1% | -30.5% | · | -19.8% | -15.6% | -18.0% | · | -12.9% | -19.5% | -18.9% | · | -28.9% | -22.4% | -25.6% | · | -21.8% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $673M | $560M | $434M | $363M | $351M |
| 영업이익률 % | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% |
| 순이익 | $-575M | $-569M | $-607M | $-707M | $-454M |
| 희석 EPS | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 |
| 당좌 비율 | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-472M | $-422M | $-519M | $-497M | $-412M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 347개의 제출자 · $2.7B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 70 (+6 이전 분기 대비) | 37 (-8 이전 분기 대비) | 113 (-13 이전 분기 대비) | 97 (+10 이전 분기 대비) | -486K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $260,338,324 | 7,796,895 | 9.48% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $226,722,608 | 6,790,135 | 8.26% | 주식 |
| STATE STREET CORP | $205,641,197 | 6,158,766 | 7.49% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $143,459,834 | 4,296,491 | 5.22% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $120,911,868 | 3,621,200 | 4.40% | 주식 |
| SANDS CAPITAL MANAGEMENT, LLC | $105,457,908 | 3,158,368 | 3.84% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $98,157,217 | 2,939,719 | 3.57% | 주식 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $95,092,590 | 2,847,936 | 3.46% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $73,869,758 | 2,211,828 | 2.69% | 주식 |
| Bellevue Group AG | $66,204,857 | 1,982,775 | 2.41% | 주식 |
| Sofinnova Investments, Inc. | $57,347,492 | 1,717,505 | 2.09% | 주식 |
| D. E. Shaw & Co., Inc. | $54,716,761 | 1,638,717 | 1.99% | 주식 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $52,756,200 | 1,580,000 | 1.92% | 주식 |
| MPM BIOIMPACT LLC | $47,354,199 | 1,418,215 | 1.72% | 주식 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $41,455,555 | 1,241,556 | 1.51% | 주식 |
| Candriam S.C.A. | $33,419,286 | 1,001,841 | 1.22% | 주식 |
| Rock Springs Capital Management LP | $32,316,678 | 967,855 | 1.18% | 주식 |
| Jefferies Financial Group Inc. | $31,040,212 | 929,626 | 1.13% | 주식 |
| Eagle Health Investments LP | $29,520,800 | 884,121 | 1.07% | 주식 |
| Qube Research & Technologies Ltd | $29,457,292 | 882,219 | 1.07% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $27,926,528 | 836,374 | 1.02% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $25,403,947 | 760,825 | 0.92% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25,377,702 | 760,039 | 0.92% | 주식 |
| Caption Management, LLC | $24,000,732 | 718,800 | 0.87% | 풋 옵션 |
| BANK OF AMERICA CORP /DE/ | $23,505,893 | 703,980 | 0.86% | 주식 |
| Pictet Asset Management Holding SA | $23,159,948 | 753,695 | 0.84% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $22,418,413 | 671,411 | 0.82% | 주식 |
| GREAT POINT PARTNERS LLC | $20,034,000 | 600,000 | 0.73% | 풋 옵션 |
| Palo Alto Investors LP | $19,916,968 | 596,495 | 0.73% | 주식 |
| SPHERA FUNDS MANAGEMENT LTD. | $19,649,815 | 588,494 | 0.72% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $19,574,220 | 586,230 | 0.71% | 주식 |
| Trexquant Investment LP | $18,577,695 | 556,385 | 0.68% | 주식 |
| BlackRock, Inc. | $18,510,448 | 554,371 | 0.67% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16,995,510 | 509,000 | 0.62% | 풋 옵션 |
| Sofinnova Investments, Inc. | $16,695,000 | 500,000 | 0.61% | 콜 옵션 |
| BNP PARIBAS FINANCIAL MARKETS | $16,633,796 | 498,167 | 0.61% | 주식 |
| TORONTO DOMINION BANK | $13,856,850 | 415,000 | 0.50% | 주식 |
| VANGUARD GROUP INC | $13,818,814 | 600,818 | 0.50% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $13,813,443 | 413,700 | 0.50% | 주식 |
| Caption Management, LLC | $13,753,341 | 411,900 | 0.50% | 콜 옵션 |
| Cutter Capital Management, LP | $13,734,562 | 379,303 | 0.50% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $13,624,489 | 408,041 | 0.50% | 주식 |
| ALGERT GLOBAL LLC | $13,020,898 | 389,964 | 0.47% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $12,735,614 | 381,420 | 0.46% | 주식 |
| AXA Investment Managers S.A. | $12,549,316 | 417,198 | 0.46% | 주식 |
| SummitTX Capital, L.P. | $12,496,875 | 374,270 | 0.46% | 주식 |
| GOLDMAN SACHS GROUP INC | $12,394,401 | 371,201 | 0.45% | 주식 |
| Privium Fund Management B.V. | $11,312,532 | 338,800 | 0.41% | 주식 |
| Squarepoint Ops LLC | $11,298,108 | 338,368 | 0.41% | 주식 |
| Walleye Capital LLC | $11,180,775 | 334,854 | 0.41% | 주식 |
| TWO SIGMA ADVISERS, LP | $11,076,800 | 481,600 | 0.40% | 주식 |
| Catalio Capital Management, LP | $10,559,654 | 316,252 | 0.38% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $9,944,000 | 297,819 | 0.36% | 주식 |
| Ensign Peak Advisors, Inc | $9,710,413 | 290,818 | 0.35% | 주식 |
| GordonMD Global Investments LP | $9,653,082 | 289,101 | 0.35% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,215,640 | 276,000 | 0.34% | 콜 옵션 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $8,929,454 | 267,429 | 0.33% | 주식 |
| FMR LLC | $8,597,725 | 257,494 | 0.31% | 주식 |
| Quantinno Capital Management LP | $8,363,060 | 250,466 | 0.30% | 주식 |
| JPMORGAN CHASE & CO | $7,279,842 | 232,755 | 0.27% | 주식 |
| KENNEDY CAPITAL MANAGEMENT LLC | $7,212,140 | 215,997 | 0.26% | 주식 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $7,157,948 | 214,374 | 0.26% | 주식 |
| CITADEL ADVISORS LLC | $7,029,630 | 210,531 | 0.26% | 주식 |
| Ishara Investments LP | $6,844,950 | 205,000 | 0.25% | 주식 |
| Man Group plc | $6,508,245 | 194,916 | 0.24% | 주식 |
| FIFTH THIRD BANCORP | $6,452,150 | 193,236 | 0.23% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $6,396,789 | 191,578 | 0.23% | 주식 |
| Blue Owl Capital Holdings LP | $6,098,283 | 182,638 | 0.22% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,039,283 | 180,871 | 0.22% | 주식 |
| Woodline Partners LP | $5,736,569 | 171,805 | 0.21% | 주식 |
| Atom Investors LP | $5,735,434 | 171,771 | 0.21% | 주식 |
| Swiss National Bank | $5,597,900 | 167,652 | 0.20% | 주식 |
| Ikarian Capital, LLC | $5,529,952 | 165,617 | 0.20% | 주식 |
| Stonepine Capital Management, LLC | $5,500,000 | 200,000 | 0.20% | 콜 옵션 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $5,260,270 | 171,456 | 0.19% | 주식 |
| BOOTHBAY FUND MANAGEMENT, LLC | $5,229,275 | 156,612 | 0.19% | 주식 |
| Cubist Systematic Strategies, LLC | $5,194,035 | 172,674 | 0.19% | 주식 |
| Eversept Partners, LP | $5,146,401 | 154,130 | 0.19% | 주식 |
| MARSHALL WACE, LLP | $5,053,810 | 151,357 | 0.18% | 주식 |
| Ghisallo Capital Management LLC | $5,008,500 | 150,000 | 0.18% | 주식 |
| Mariner, LLC | $4,887,301 | 146,400 | 0.18% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $4,841,550 | 145,000 | 0.18% | 주식 |
| FRED ALGER MANAGEMENT, LLC | $4,779,945 | 143,155 | 0.17% | 주식 |
| Corient Private Wealth LP | $4,644,350 | 139,094 | 0.17% | 주식 |
| SR One Capital Management, LP | $4,599,573 | 137,753 | 0.17% | 주식 |
| B Group, Inc. | $4,507,650 | 135,000 | 0.16% | 주식 |
| PINNACLE ASSOCIATES LTD | $4,377,563 | 131,104 | 0.16% | 주식 |
| Caption Management, LLC | $4,340,700 | 130,000 | 0.16% | 주식 |
| MOORE CAPITAL MANAGEMENT, LP | $4,275,089 | 128,035 | 0.16% | 주식 |
| RHUMBLINE ADVISERS | $4,144,518 | 124,125 | 0.15% | 주식 |
| Apollon Wealth Management, LLC | $4,121,962 | 123,449 | 0.15% | 주식 |
| Odyssean, LLC | $4,076,485 | 122,087 | 0.15% | 주식 |
| Assenagon Asset Management S.A. | $4,035,649 | 120,864 | 0.15% | 주식 |
| EFG Asset Management (North America) Corp. | $3,848,509 | 127,985 | 0.14% | 주식 |
| BARCLAYS PLC | $3,742,919 | 112,097 | 0.14% | 주식 |
| IEQ CAPITAL, LLC | $3,540,194 | 106,026 | 0.13% | 주식 |
| Rafferty Asset Management, LLC | $3,394,260 | 101,655 | 0.12% | 주식 |
| Crestwood Advisors Group, LLC | $3,348,149 | 100,274 | 0.12% | 주식 |
| Tetragon Partners GP Ltd | $3,339,000 | 100,000 | 0.12% | 콜 옵션 |
| CITADEL ADVISORS LLC | $3,308,949 | 99,100 | 0.12% | 풋 옵션 |
회사 내부자 28 명의 내부자 · 15 임원 · 11 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Emil D Kakkis | President & CEO | 2026년 4월 16일 A | 735,739 | 0 | 1 | $-1,240,411 |
| Howard Horn | Chief Financial Officer | 2026년 8월 3일 S | 96,295 | 0 | 12 | $-1,332,021 |
| Mardi Dier | CFO & Executive Vice President | 2022년 10월 14일 S | 66,695 | 0 | 0 | $0 |
| Wladimir Hogenhuis | Chief Operating Officer | 2019년 10월 4일 F | 18,703 | 0 | 0 | $0 |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | 2026년 8월 3일 S | 92,562 | 0 | 5 | $-487,890 |
| Eric Crombez | EVP and Chief Medical Officer | 2026년 5월 5일 S | 111,189 | 0 | 2 | $-168,847 |
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | 2026년 4월 22일 A | 68,911 | 0 | 4 | $-44,636 |
| Erik Harris | EVP & Chief Commercial Officer | 2026년 4월 16일 A | 118,410 | 0 | 1 | $-240,289 |
| John Richard Pinion | EVP, Chief Quality Operations Officer | 2026년 4월 16일 A | 133,142 | 0 | 1 | $-228,661 |
| Dennis Karl Huang | EVP, Chief Technical Operations Officer | 2026년 4월 16일 A | 147,845 | 0 | 0 | $0 |
| Thomas Richard Kassberg | CBO & EVP | 2025년 3월 3일 F | 264,730 | 0 | 0 | $0 |
| Camille L Bedrosian | EVP and Chief Medical Officer | 2023년 3월 1일 S | 46,720 | 0 | 0 | $0 |
| Shalini Sharp | EVP, Finance | 2020년 10월 14일 S | 97,812 | 0 | 0 | $0 |
| Jayson Donald Alexander Dallas | EVP & Chief Commercial Officer | 2018년 6월 1일 F | 23,830 | 0 | 0 | $0 |
| Sunil Agarwal | Chief Medical Officer | 2015년 5월 21일 A | 29,400 | 0 | 0 | $0 |
| Corazon (Corsee) D. Sanders | 이사 | 2026년 6월 15일 S | 21,095 | 0 | 1 | $-50,100 |
| Deborah Dunsire | 이사 | 2026년 5월 14일 A | 38,566 | 0 | 0 | $0 |
| Daniel G Welch | 이사 | 2026년 5월 14일 A | 40,441 | 0 | 0 | $0 |
| Amrit Ray | 이사 | 2025년 5월 15일 A | 23,365 | 0 | 0 | $0 |
| Shehnaaz Suliman | 이사 | 2025년 5월 15일 A | 25,940 | 0 | 0 | $0 |
| Lars Ekman | 이사 | 2022년 6월 24일 A | 17,745 | 0 | 0 | $0 |
| William Aliski | 이사 | 2021년 6월 24일 A | 66,849 | 0 | 0 | $0 |
| Clay B Siegall | 이사 | 2020년 8월 10일 M | 2,550 | 0 | 0 | $0 |
| Eran Nadav | 이사 | 2014년 7월 10일 A | — | 0 | 0 | $0 |
| Marten Steen | 이사 | 2014년 1월 30일 A | — | 0 | 0 | $0 |
| Matthew K Fust | — | 2026년 5월 14일 A | 33,696 | 0 | 0 | $0 |
| Michael Narachi | — | 2026년 5월 14일 A | 40,441 | 0 | 0 | $0 |
| FMR LLC | — | 2014년 8월 1일 J | 1,457,994 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2020년 11월 6일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 48 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| TMFS · RBB Fund, Inc. | 3.03% | 74,931 NS | 2026년 5월 31일 | N-PORT |
| GNOM · Global X Funds | 2.25% | 52,426 NS | 2026년 5월 31일 | N-PORT |
| HAPS · Harbor ETF Trust | 1.31% | 83,707 NS | 2026년 4월 30일 | N-PORT |
| BBP · ETFis Series Trust I | 1.09% | 26,120 NS | 2026년 4월 30일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.85% | 178,057 NS | 2026년 4월 30일 | N-PORT |
| MMLG · First Trust Exchange-Traded Fund VI… | 0.36% | 13,877 NS | 2026년 5월 31일 | N-PORT |
| ESSC · Strategy Shares | 0.31% | 3,204 NS | 2026년 4월 30일 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.13% | 54,688 NS | 2026년 4월 30일 | N-PORT |
| BIB · ProShares Trust | 0.12% | 3,571 NS | 2026년 5월 31일 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 34,325 NS | 2026년 4월 30일 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.11% | 9,780 NS | 2026년 5월 31일 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.10% | 3,381 NS | 2026년 4월 30일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 463,045 NS | 2026년 5월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 39,736 NS | 2026년 4월 30일 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.03% | 5,097 NS | 2026년 4월 30일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 3,648 NS | 2026년 5월 31일 | N-PORT |
| GGUS · Goldman Sachs ETF Trust | 0.01% | 1,628 NS | 2026년 5월 31일 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 32,531 NS | 2026년 5월 31일 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 3,080 NS | 2026년 4월 30일 | N-PORT |
| JUST · Goldman Sachs ETF Trust | 0.00% | 859 NS | 2026년 5월 31일 | N-PORT |
| RECS · Columbia ETF Trust I | 0.00% | 7,427 NS | 2026년 4월 30일 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 56,898 NS | 2026년 5월 31일 | N-PORT |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,007 NS | 2026년 5월 31일 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 129 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VBK · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 2026년 7월 15일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026년 7월 15일 | 일간 |
| ITOT · iShares Trust | — | — | 2026년 8월 5일 | 일간 |
| IWV · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWN · iShares Trust | — | — | 2026년 8월 17일 | 일간 |
| IWO · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IWM · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| IBB · iShares Trust | — | — | 2026년 8월 18일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026년 7월 28일 | 일간 |
| VHT · VANGUARD WORLD FUND | — | — | 2026년 7월 20일 | 일간 |
| ESGV · VANGUARD WORLD FUND | — | — | 2026년 7월 30일 | 일간 |
| ISCB · iShares Trust | — | — | 2026년 8월 5일 | 일간 |
| ISCG · iShares Trust | — | — | 2026년 8월 5일 | 일간 |
| ISCV · iShares Trust | — | — | 2026년 8월 5일 | 일간 |
| ESML · iShares Trust | — | — | 2026년 8월 14일 | 일간 |
| WSML · iShares Trust | — | — | 2026년 8월 5일 | 일간 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 2026년 7월 20일 | 일간 |